Citigroup Initiates Coverage of Evolent Health (EVH) with Buy Recommendation

3d ago, source: Fintel on MSN

Fintel reports that on April 22, 2024, Citigroup initiated coverage of Evolent Health (NYSE:EVH) with a Buy recommendation.

In-Depth Examination Of 6 Analyst Recommendations For Evolent Health

3d ago, source:

Analysts have set 12-month price targets for Evolent Health, revealing an average target of $44.0, a high estimate of $52.00, and a low estimate of $38.00. A 3.3% drop is evident in the current ...

RBC Capital Keeps Their Buy Rating on Stericycle (SRCL)

4h ago, source:

In a report released yesterday, Sean Dodge from RBC Capital maintained a Buy rating on Stericycle (SRCL – Research Report), with a price ...

World's Best Digital Health Companies 2024 - Newsweek Rankings

1d ago, source:

Newsweek is partnering with Statista for the inaugural ranking of the World's Best Digital Health Companies. The list ...

Daily Digest: First Republic brand to disappear; Tesla settles over Apple engineer's death

17d ago, source: The Business Journals

Define Ventures announced health care leader Frank Williams has joined its team as venture partner. Williams is the ...

Buy Rating Justified: Biogen’s Promising Drug Launches and Strategic Growth Initiatives

8h ago, source:

Analyst Salim Syed from Mizuho Securities assigned a Buy rating on Biogen (BIIB – Research Report) and keeping the price target at ...

Elevance Health Clocks $2.2B Q1 Net Profit Despite 21% Drop In Medicaid Enrollment, Lifts Annual Guidance

on MSN ago, source:

Elevance Health Inc. (NYSE:ELV) reported first-quarter revenues of $42.3 billion, up 0.9% year over year, marginally missing ...

Clinical Risk Grouping Solutions Market Key Segments, Share, Size, Growth Analysis and Forecast to 2024 to 2032

7d ago, source: Taiwan News

Request To Download Free Sample of This Strategic Report @ Clinical Risk Grouping Solutions Market is valued approximately ...